Equillium, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for EQ, updated each market day.
EQ AI Sentiment
AI predicts Equillium, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Equillium, Inc. Common Stock
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
Sector
Exchange
Market Cap
$119,841,274
Cap Tier
Employees
14
Headquarters
LA JOLLA, CA
Listed Since
Oct. 12, 2018
Website
EQ Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
EQ Volatility
Equillium, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
